B-type Diagnostic Ultrasound Devices Market, By Type (Fan shaped Scanning, Linear Scanning, and Mixed Type), By Application (Radiology/Oncology, Cardiology, Obstetrics & Gynaecology, and Mammography/Breast), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

B-type Diagnostic Ultrasound Devices Market was valued at USD 9.0 Billion in 2024 and is projected to grow at a CAGR of 6.5% to reach USD 16.0 Billion by 2034.

With ongoing technological advancements, the future of B-type diagnostic ultrasound devices promises even greater accuracy, accessibility, and clinical applications. This will lead to the rapid growth of the B-type Diagnostic Ultrasound Devices Market since the rise in several disease cases and the technical advancement in medical biotechnology will drive the increase in demand for such diagnostic tools.

In 2023 it was estimated by the WHO and the AHA that around 620 million people are suffering from circulatory diseases worldwide with nearly 60 million new cases being added each year. Circulatory diseases which are commonly detected using B-Type Diagnostic Ultrasound Devices like echocardiograms, caused an estimated 20.5 million deaths globally, in 2021.

B-type Diagnostic Ultrasound Devices Market Key Drivers:

• Rising prevalence of chronic diseases and growing geriatric population

Rising cases of chronic disease have become the major factor in B-type Diagnostic Ultrasound Devices Market growth. The need for early and accurate diagnosis of medical conditions as a means to prevent disease is driving the demand for B-Type Diagnostic Ultrasound Devices across the globe. As the number of elderly people increases globally, due to their higher disease susceptibility the need for non-invasive imaging tools for regular diagnosis and treatment will drive the B-type Diagnostic Ultrasound Devices Market expansion.

According to the CDC (Centre for Disease Control and Prevention), in the United States, around 1,958,310 new cases of Cancer along with 609,820 cancer-related deaths people were estimated to occur in 2023. The need for early diagnosis as a part of preventive treatment for such severe diseases will benefit the growth of the B-type Diagnostic Ultrasound Devices Market.

• Implementation of Point- Of- Care Ultrasound

The increasing preference for point-of-care B-Type Diagnostic Ultrasound Devices will become a driving factor for the growth of the B-type Diagnostic Ultrasound Devices Market. Their portability and capacity to provide real-time imaging helps examiners make prompt diagnostic and treatment decisions which simplify the healthcare process and can be applied to a wide range of medical fields.

• Technological advancement

Technological advancement and continuous innovation in Ultrasound Devices have become major factors in B-type Diagnostic Ultrasound Devices Market growth. Incorporating features such as 3D/4D imaging, AI (artificial intelligence) tools, more portability, etc. into B-Type Diagnostic Ultrasound Devices has increased their versatility and helps provide a faster, more accurate diagnosis of diseases. Investment in better medical imaging technology is a crucial driver for growth in B-type Diagnostic Ultrasound Devices Market

B-type Diagnostic Ultrasound Devices Market Restraints:

As of now, the accuracy of ultrasound imaging is largely dependent on the skill of the medical technicians involved as most B-Type Diagnostic Ultrasound Devices are not fully automated. This as well as the high cost involved in procuring and maintaining quality B-Type Diagnostic Ultrasound Devices and hiring of trained operators, poses a significant challenge to the steady growth of the current B-type Diagnostic Ultrasound Devices Market.

B-type Diagnostic Ultrasound Devices Market is segmented based on Type, By Application and by Region.

Type Insight

On the basis of Type, the B-type Diagnostic Ultrasound Devices Market is segmented into Fan-shaped Scanning, Linear Scanning, and Mixed Type. The Mixed Type segment occupies the largest market share in the current B-type Diagnostic Ultrasound Devices Market. This is primarily due to its versatile applications in different medical categories ranging from gynaecology to cardiology. It allows medical practitioners to customise the imaging test according to their diagnostic needs.

Application Insights

On the basis of applications, B-type Diagnostic Ultrasound Devices Market is segmented into Radiology/Oncology, Cardiology, Obstetrics & Gynaecology, and Mammography/Breast. Of these, currently, the Radiology/Oncology segment has the maximum market share followed closely by the cardiology sector. This is due to the rising number and severity of cancer cases across the globe and the diverse applications of radiology in medicine ranging from evaluating injuries to tracking treatment progress. B-Type Diagnostic Ultrasound Devices are the most commonly used tools for accurately detecting the presence of tumour tissue.

Regional Insights:

B-type Diagnostic Ultrasound Devices Market Regional Insights:

In the region, the B-type Diagnostic Ultrasound Devices Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America market is estimated to witness a significantly high revenue share over the forecast period, owing to the rising prevalence of chronic diseases of the cardiovascular system, cancer cases, presence of a majority of market key players and collaborative efforts between them, advancement in imaging technology and AI tools, and increased investment on research & development activities to create a robust healthcare infrastructure.

Asia Pacific market is estimated to witness the fastest revenue share due to the population explosion and the quality of lifestyle of individuals there. As the ageing population increases need for point-of-care diagnostics also increases and overall expenditure on healthcare is increased.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the B-type Diagnostic Ultrasound Devices Market report based on type, applications and region:

B-type Diagnostic Ultrasound Devices Market, By Type:

• Fan shaped Scanning
• Linear Scanning
• Mixed Type

B-type Diagnostic Ultrasound Devices Market, By Application:

• Radiology/ Oncology
• Cardiology
• Obstetrics/ Gynaecology
• Mammography/ Breast

B-type Diagnostic Ultrasound Devices Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the B-type Diagnostic Ultrasound Devices Market includes, General Electric (GE),Philips, Siemens, TOSHIBA, Hitachi Medical, Mindray, Sonosite (FUJIFILM), Esaote, Samsung Medison, Konica Minolta and Others.

• General Electric (GE)
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Philips
• Siemens
• TOSHIBA
• Hitachi Medical
• Mindray
• Sonosite (FUJIFILM )
• Esaote
• Samsung Medison
• Konica Minolta

“*” marked represents similar segmentation in other categories in the respective section

Recent Development:

• In July 2023, MIT researchers successfully designed a wearable B-Type Diagnostic Ultrasound Device that will help detect tumours in their early stages. This was developed with hopes to increase the survival rate of breast cancer patients as it has been observed that early stage tumour detection allows for a 100% survival rate whereas later stage detection lowers the patient survival rate to a meagre 25%. The portable device comes as a wearable patch attached to a bra and can be operated by patients themselves to get high-res images of the breast tissue.
• In July 2023, Canon Medical Systems Corporation announced the launch of their line of premium small Diagnostic Ultrasound Devices, the Aplio flex and the Aplio go. These devices are set to provide exceptional portability and a range of versatile clinical applications to users. Their sleek design and lightweight construction allows for comfortable stationary s well as mobile use.
• In June 2023, Koninklijke Philips N.V. demonstrated their Ultrasound Compact 5500CV at a major healthcare event in the U.S. The device offers next generation imaging technology and single point of access to data anytime, anywhere. This will help revolutionise imaging accuracy and improve efficiency of clinical diagnosis of cardiovascular diseases.
• In February 2023, GE Healthcare acquired leading AI integrated healthcare solutions provider, Caption Health, Inc. This acquisition will allow them to provide affordable point of care diagnostic services with AI integrated imaging technology to a huge medical devices market. With this development patients can avail affordable, highly accurate, rapid diagnostic services, while medical practitioners across a wide range of fields will also benefit from the versatile range of applications of AI enabled B-Type Diagnostic Ultrasound Devices.
• In January 2023,  Esaote SPA launched its new MyLabX90 device. The B-Type Diagnostic Ultrasound Device is set to provide revolutionising image resolution and on screen image display quality which will allow medical examiners to diagnose internal tissue abnormalities more accurately.